Aino Health AB (AINO) AI Stock Analysis

• Market Cap: kr55.64M
• Dividend Yield: N/A
• Average Volume (3M): 40.05K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.37
• Revenue Growth: 0.10%
• EPS Growth: 41.59%
• Country: SE
• Employees: 19
• Sector: Healthcare
• Sector Strength: 42
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.02
• Shares Outstanding: 204,569,100
• 10 Day Avg. Volume: 102,604
• 30 Day Avg. Volume: 40,049
• PEG Ratio: -0.40
• Price to Book (P/B): -121.49
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -12.15
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 29 Underperform
• Price Target: ―

Aino Health AB's overall stock score reflects significant financial weaknesses, including persistent losses and negative equity. The bearish technical indicators compound concerns about its short-term market performance. Despite some minor revenue improvement, the company's negative valuation metrics highlight its ongoing operational challenges, making it a high-risk investment.

Aino Health AB Business Overview & Revenue Model

Company Description

Aino Health AB is a Swedish company specializing in corporate health management solutions. The company operates primarily in the technology sector, offering digital platforms designed to improve workplace health and well-being. Aino Health's core services include health data analytics, management tools for employee health and productivity, and solutions to reduce sick leave and improve workplace efficiency.

How the Company Makes Money

Aino Health AB generates revenue through a subscription-based model, where businesses pay for access to its digital health management platform. The platform provides tools and analytics that help organizations monitor and enhance employee health and productivity. Key revenue streams include subscription fees for the platform, consultancy services related to health management, and partnerships with healthcare providers. The company may also generate income through additional services such as training and workshops aimed at promoting healthy workplace practices.

Aino Health AB Financial Statement Overview

Summary

Aino Health AB faces significant financial challenges, with persistent losses, negative equity, and cash flow difficulties. While there are minor improvements in revenue, the company must address profitability and cash flow issues to stabilize its financial position and ensure long-term sustainability.

Income Statement

The company has experienced fluctuating revenues with a slight increase in the latest year. Gross profit margin remains high, but negative EBIT, EBITDA, and net profit margins indicate ongoing operational challenges. Revenue growth is stagnant with a slight increase in 2024, but profitability remains a significant concern.

Balance Sheet

The company's financial structure is weak, with negative stockholders' equity and a lack of debt. The negative equity and high liabilities suggest potential solvency risks. The lack of leverage may indicate limited financing options or a strategic choice to minimize debt.

Cash Flow

The company consistently reports negative operating and free cash flows, reflecting cash management challenges. Although there is some improvement in financing cash flow, it is insufficient to offset the negative operating cash flows, indicating a need for cash flow improvements.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
23.94M	23.92M	19.91M	23.04M	24.92M
	Gross Profit
21.51M	3.80M	17.77M	21.56M	23.61M
	EBIT
-9.20M	-9.51M	-14.56M	-14.18M	-13.98M
	EBITDA
-6.21M	-7.53M	-12.26M	-12.09M	-9.95M
	Net Income Common Stockholders
-9.91M	-10.66M	-15.37M	-16.52M	-12.77M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
741.00K	1.44M	2.16M	453.00K	9.00M
	Total Assets
9.86M	13.51M	17.33M	19.02M	33.38M
	Total Debt
0.00	164.00K	659.00K	1.06M	1.49M
	Net Debt
-741.00K	-1.27M	-1.50M	608.00K	-7.51M
	Total Liabilities
10.32M	14.37M	19.57M	16.44M	17.36M
	Stockholders Equity
-458.00K	-851.00K	-2.23M	2.58M	16.02M
Cash Flow		Free Cash Flow
-4.55M	-6.26M	-12.87M	-8.11M	-12.07M
	Operating Cash Flow
-4.55M	-6.26M	-12.87M	-8.11M	-12.07M
	Investing Cash Flow
0.00	0.00	1.32M	0.00	1.69M
	Financing Cash Flow
3.82M	5.57M	13.19M	-450.00K	16.38M

Aino Health AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.27
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AINO, the sentiment is Positive. The current price of 0.27 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.18, and above the 200-day MA of 0.17, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 71.62 is Negative, neither overbought nor oversold. The STOCH value of 91.47 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:AINO.

Aino Health AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
KONT	59 Neutral	kr75.79M	325.76	0.25%	―	0.84%	-79.94%
CMOTEC.B	54 Neutral	kr48.56M	―	-236.60%	―	132.67%	58.89%
Sector *	54 Neutral	$5.31B	3.28	-45.10%	2.80%	16.76%	0.02%
PROGEN	35 Underperform	kr40.73M	―	-139.61%	―	-85.32%	92.64%
STABL	34 Underperform	kr29.19M	―	-105.54%	―	―	63.82%
HEART	34 Underperform	kr69.48M	―		―	―	―
AINO	29 Underperform	kr55.64M	―		―	0.10%	41.59%